Progressive Myopia

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large studies published in Investigative Ophthalmology & Visual Science.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Nick Ruth, MBA, of Sydnexis previews upcoming data for a progressive myopia treatment for pediatric patients.

Myopia is the most common refractive error in the United States and globally. Today, about 42% of Americans, or 141 million individuals, are myopic.

In 1980, while helping the late George O. Waring III prepare the grant application for the soon to be initiated Prospective Evaluation of Radial Keratotomy study, I reviewed the world literature on the incidence and prevalence of myopia.

Santen and Sydnexis have finalized an exclusive licensing agreement for SYD-101 in Europe, Middle East and Africa for the treatment of progressive childhood myopia, according to a press release.

Drug shortage, including ophthalmic eye drops, is becoming a meaningful problem for doctors and patients, especially for generic eye drops in which there is minimal financial incentive to the manufacturer.

Euclid Systems Corp. has released the Max orthokeratology lens, designed to reshape patients’ corneas during overnight wear for the temporary reduction of myopia.

A five-step strategy, based on functional aspects and pathogenetic considerations, could help prevent the onset and reduce the progression of myopia in children and adults.

KOLOA, Hawaii — At Hawaiian Eye 2020, Jack T. Holladay, MD, MSEE, discusses research he has been examining to reduce the global progressive myopia epidemic, looking at the use of prisms, as well as performing cross-linking of the sclera.

I like the concept of lifetime management of refractive errors. I have a few thoughts as to how this might be accomplished.